



Semaglutide
A long-acting GLP-1 receptor agonist studied for incretin signaling and glucose-metabolism research.
- Free cold-chain shipping over $200
- Signed COA included with every vial
- Batch-pinned ordering for protocol continuity
Research Use Only. Sold for research and identification purposes only. Not intended for human dosing, injection, or ingestion.
Mass-Spec Verified
HPLC + LC-MS per batch at Janoshik.
99% Purity Threshold
Below-spec lots are destroyed, not sold.
Cold-Chain 2–8°C
Continuous transit temperature logging.
U.S. cGMP Compounded
Domestic manufacturing, lot traceability.
Mechanism of action
Semaglutide is a long-acting synthetic analog of glucagon-like peptide-1, acting as an agonist of the GLP-1 receptor. Research models study its role in incretin signaling, glucose-dependent insulin secretion, and energy-homeostasis pathways.
As one of the most extensively studied GLP-1 receptor agonists, it serves as a common comparison standard in metabolic-pathway research.


